Found 25 matching trials
Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash PHASE2 The investigators hypothesized that topical anti-inflammatory treatment cou...
Show More Location
Davidoff Center, Rabin Medical Center, Beilinson
Learn More & Join Trial
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial PHASE3 This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy PHASE1 This was an open-label, phase Ib, multicenter clinical trial to determine t...
Show More Location
Massachusetts General Hospital Head & Neck
Learn More & Join Trial
Combination of Gatipotuzumab and Tomuzotuximab in Patients With Solid Tumors PHASE1 This was a single arm phase Ib study to evaluate the safety and efficacy of...
Show More Location
Glycotope-contracted research facility
Learn More & Join Trial
AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer N/A Observational study investigating the relationship between tumour amphiregu...
Show More Location
Calderdale and Huddersfield NHS Foundation Trust
Learn More & Join Trial
Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer PHASE1 The purpose of this study is to test a new drug combination consisting of t...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
A Study of Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People With Metastatic Colorectal Cancer PHASE2 The purpose of this study is to evaluate the efficacy and toxicity of irino...
Show More Status
Active Not Recruiting
Location
Blokhin's Russian Cancer Research Center
Learn More & Join Trial
Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study PHASE2 This prospective Phase II study aims to evaluate the efficacy and safety of...
Show More Location
Al Hussien University Hospital
Learn More & Join Trial
Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment N/A Up to 60% of patients with metastatic colorectal cancer can be treated with...
Show More Location
Department of Gastrointestinal Cancer, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology
Learn More & Join Trial
Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE) PHASE2 The purpose of this study was to assess the preliminary antitumor activity,...
Show More Learn More & Join Trial